MediaWiki API result

{
    "batchcomplete": "",
    "continue": {
        "gapcontinue": "Reactive_follicular_hyperplasia",
        "continue": "gapcontinue||"
    },
    "warnings": {
        "main": {
            "*": "Subscribe to the mediawiki-api-announce mailing list at <https://lists.wikimedia.org/mailman/listinfo/mediawiki-api-announce> for notice of API deprecations and breaking changes."
        },
        "revisions": {
            "*": "Because \"rvslots\" was not specified, a legacy format has been used for the output. This format is deprecated, and in the future the new format will always be used."
        }
    },
    "query": {
        "pages": {
            "391": {
                "pageid": 391,
                "ns": 0,
                "title": "Reactive atypia",
                "revisions": [
                    {
                        "contentformat": "text/x-wiki",
                        "contentmodel": "wikitext",
                        "*": "'''Reactive atypia''' is a term that may be confusing as it contains the word \"atypia\"; some say it should ''not'' be used.<ref>GHH. 17 November 2010.</ref>  \n\nGenerally, it is understood as changes due to inflammation or injury without neoplastic change. \n\nA less confusing categorization is:\n# Reactive (benign).\n# Dysplastic (pre-malignant). \n# [[Indefinite for dysplasia]] (\"I don't know\").\n\nReactive atypia may confuse people between #1 and #2.\n\n''Reactive atypia'' is used by Sternberg.<ref>{{Ref Sternberg4|2055}}</ref>\n\n==See also==\n*[[Reactive squamous epithelium of the uterine cervix]].\n\n==References==\n{{Reflist|1}}\n\n[[Category:Rants]]"
                    }
                ]
            },
            "3586": {
                "pageid": 3586,
                "ns": 0,
                "title": "Reactive changes",
                "revisions": [
                    {
                        "contentformat": "text/x-wiki",
                        "contentmodel": "wikitext",
                        "*": "'''Reactive changes''' is a commonly used term in [[pathology]] that implies:\n# Inflammation.\n# Nuclear changes compatible with inflammation.\n# The absence of both neoplasia ''and'' the suspicion of neoplasia, i.e. it implies benignancy.\n\n'''Reactive inflammatory changes''' and '''inflammatory changes''' can be considered synonyms.\n\n==General==\nNuclear changes are seen in: \n*Inflammatory processes.\n*Repair.\n*Neoplastic processes, i.e. pre-cancerous conditions (e.g. dysplasia) and [[cancer]].  \n\nSignificance of nuclear changes in inflammation:\n*The line between a reactive process and a neoplastic process may be fuzzy, i.e. it may be very difficult to be certain whether something is benign or [[malignant]]. \n\nConsequence:\n*In the context of inflammation, nuclear changes are typically present and the threshold for calling ''suspicious for malignancy'' or ''[[malignancy]]'' is typically higher.\n\n==Microscopic==\nFeatures - generic:\n*Nuclear changes - typically:\n**Nuclear enlargement.\n**Nuclear hyperchromasia.\n**Prominent [[nucleoli]].\n*Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic).\n*+/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia).\n\nNotes:\n*Cytoplasmic changes may be present.\n\nDDx:\n*Normal.\n*[[Waffle diagnosis]] - nuclear changes of unknown significance.\n**Terminology dependent on the anatomical site, e.g. [[indefinite for dysplasia]], [[ASCUS]], [[ASAP]]. \n*[[Nuclear atypia]].\n**This is often qualified as it may represent a neoplastic process or a benign process.\n**Common qualifiers:\n***Worrisome lesions: \"... cannot exclude dysplasia\", \"... cannot exclude malignancy\", \"... suspicious for malignancy\". \n***Suspected to be benign: \"... favour benign\".\n*[[Malignancy]].\n\n==See also==\n*[[Reactive atypia]].\n*[[Nuclear atypia]].\n*[[NC ratio]].\n*[[Reactive squamous epithelium of the uterine cervix]].\n*[[Reactive astrocytes]].\n\n[[Category:Stuff]]"
                    }
                ]
            }
        }
    }
}